Liraglutide Alleviates Hepatic Steatosis by Activating the TFEB-Regulated Autophagy-Lysosomal Pathway

Liraglutide, a glucagon-like peptide-1 receptor agonist (GLP-1RA), has been demonstrated to alleviate non-alcoholic fatty liver disease (NAFLD). However, the underlying mechanism has not been fully elucidated. Increasing evidence suggests that autophagy is involved in the pathogenesis of hepatic ste...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Cell Dev Biol
Главные авторы: Fang, Yunyun, Ji, Linlin, Zhu, Chaoyu, Xiao, Yuanyuan, Zhang, Jingjing, Lu, Junxi, Yin, Jun, Wei, Li
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2020
Предметы:
Cell and Developmental Biology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729067/
https://ncbi.nlm.nih.gov/pubmed/33330497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2020.602574
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы